(Q33374901)

26 July 2017

Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis (English)

1 reference

antiphospholipid syndrome

26 July 2017

1 reference

4

Y Shoenfeld

1 reference

26 July 2017

3

M Blank

1 reference

26 July 2017

1

I Krause

1 reference

26 July 2017

2

L Leibovici

1 reference

26 July 2017

1 January 2007

1 reference

26 July 2017

1 reference

26 July 2017

16

1 reference

26 July 2017

3

1 reference

26 July 2017

176-180

1 reference

Systemic antiphospholipid syndrome.

26 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Cardiac valvulopathy in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Antiphospholipid syndrome: five year follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Patterns of multiple resistance to antibiotics in gram-negative bacteria demonstrated by factor analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Migraine is associated with livedo reticularis: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Autoimmune hemolytic anaemia in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Tissue factor pathway and the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying 'membrane stress syndrome' hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203306075977

21 January 2018

Identifiers

DOI

10.1177/0961203306075977

1 reference

26 July 2017

1 reference

PubMed ID

17432102